The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MENLO PARK, Calif., Jan. 12 Acclarent, Inc., a leadingmedical technology company dedicated to designing, developing andcommercializing devices that address conditions affecting the ear, nose andthroat ...

Johnson & Johnson MedTech has agreed to sell its Acclarent portfolio of ear, nose and throat devices to Integra LifeSciences, which hopes to provide hardware for a range of procedures aimed at the ...

New tools build upon company's minimally-invasive Balloon Sinuplasty™ Platform to improve visualization capabilities during sinus surgery for the treatment of chronic rhinosinusitis. Since 2005, more ...

A Johnson & Johnson subsidiary has agreed to pay $18 million to resolve charges of causing health care providers to submit false claims to Medicare and other federal health care programs, which then ...

CHEVY CHASE, Md., Dec. 16 New Enterprise Associates, Inc. (NEA), a leading global venture capital firm, today announced that one of its portfolio companies, Acclarent, Inc., has entered into a ...

First cases completed with TruDi Navigation System that allows ENT real-time navigation in the O.R. and surgeon office Acclarent, Inc., part of the Johnson & Johnson Medical Devices Companies and a ...

PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first ...

The settlement comes two days after Acclarent's former CEO William Facteau and former Vice President of Sales Patrick Fabian were convicted of 10 misdemeanor counts of introducing adulterated and ...